Lipomics Technologies

Lipomics Technologies is a biotechnology company founded in 2000 and based in West Sacramento, California. Specializing in metabolic and cardiovascular health, the company offers advanced diagnostic solutions and comprehensive data visualization tools. Their focus areas include high-density lipoprotein function, insulin resistance, weight management, and inflammation. Lipomics provides quantitative metabolite profiling, bioinformatic analysis, biological interpretation, and metabolic assessments catering to drug research, clinical diagnostics, and personalized medicine. Their TrueMass Profiling suite comprises the TrueMass Lipomic Panel, TrueMass Fatty Acid Oxidation Panel, and TrueMass Cholesterol Metabolism Panel, addressing key pathways related to metabolic, cardiovascular, and inflammatory conditions. Moreover, the company's TrueView Display services encompass Lipomic Surveyor and Insight Pathway Map, designed for effective visualization and display of data generated from their platforms. As a subsidiary of Tethys BioScience, Inc., Lipomics Technologies continues to pioneer innovative solutions in the realm of metabolic and cardiovascular diseases within the biotechnology and health care industries.